Back to MORGAN STANLEY MORGAN STANLEY

SLNSLN
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in Silence Therapeutics PLC Sponsored ADR

MORGAN STANLEY holds 403,172 shares of SLN (Silence Therapeutics PLC Sponsored ADR), worth $4.4M as of 2026-Q2. The position was increased (+515.7% shares). SLN represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$4.4M

Current Shares

403,172

Total Value Change

-$8.7M

Total Shares Change

-318,245

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
403,172
+515.7%
$4.4M0.0%$10.98
43
2026-Q1
Decreased
65,486
-79.8%
$345,1120.0%$5.66
0
2025-Q4
Decreased
324,630
-73.1%
$2M0.0%$6.15
0
2025-Q3
Decreased
1.2M
-0.3%
$6.3M0.0%$5.67
0
2025-Q2
Decreased
1.2M
-39.4%
$7M0.0%$5.79
0
2025-Q1
Increased
2M
+20.3%
$5.6M0.0%$3.44
32
2024-Q4
Increased
1.7M
+130.5%
$11.4M0.0%$6.91
45
2024-Q3
Increased
721,417
+137.3%
$13.1M0.0%$18.25
45

Other major holders of SLN: MILLENNIUM MANAGEMENT LLC, Janus Henderson Group Ltd., Polar Capital Holdings Plc

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used